Optivar
Loading...Optivar Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
OPTIVAR® is for ocular use only and not for injection or oral use.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
OPTIVAR® is indicated for the treatment of itching of the eye associated with allergic conjunctivitis.
History
There is currently no drug history available for this drug.
Other Information
OPTIVAR® (azelastine hydrochloride ophthalmic solution), 0.05% is a sterile ophthalmic solution containing azelastine hydrochloride, a relatively selective H1-receptor antagonist for topical administration to the eyes. Azelastine hydrochloride is a white crystalline powder with a molecular weight of 418.37. Azelastine hydrochloride is sparingly soluble in water, methanol and propylene glycol, and slightly soluble in ethanol, octanol, and glycerine. Azelastine hydrochloride is a racemic mixture with a melting point of 225°C. The chemical name for azelastine hydrochloride is (±)-1-(2H)-phthalazinone,4-[(4-chlorophenyl) methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)-, monohydrochloride and is represented by the following chemical structure:
Empirical chemical structure: C22H24ClN3O•HCl
Each mL of OPTIVAR® contains: Active: 0.5 mg azelastine hydrochloride, equivalent to 0.457 mg of azelastine base; Preservative: 0.125 mg benzalkonium chloride; Inactives: disodium edetate dihydrate, hypromellose, sorbitol solution, sodium hydroxide and water for injection. It has a pH of approximately 5.0 to 6.5 and an osmolarity of approximately 271 to 312 mOsmol/L.
Sources
Optivar Manufacturers
-
Meda Pharmaceuticals Inc.
![Optivar (Azelastine Hydrochloride) Solution/ Drops [Meda Pharmaceuticals Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Optivar | Meda Pharmaceuticals Inc.
The recommended dose is one drop instilled into each affected eye twice a day.
Login To Your Free Account